YourDirectTest.com ▶

test directorySearch Results

Click here to search again.


Test Name:
Interstitial Lung Disease Panel


  • TMF No:
    47567
  • Performance Lab Name:
    ARUP Laboratories
  • Test Mnemonic:
    ILD PAN
  • CPT Code:
    83516x8; 86039; 86200; 86235x5; 86431
  • Ref Lab Test No:
    2013993
  • Test Includes:
    ANA, IgG by IFA
    CCP Ab, IgG
    EJ (glycyl-tRNA synthetase) Ab
    Jo-1 (Histidyl-tRNA Synthetase) Ab, IgG
    Ku Ab
    MDA5 (CADM-140) Ab
    NXP-2 (Nuclear matrix protein-2) Ab
    OJ (isoleucyl-tRNA synthetase) Ab
    PL-12 (alanyl-tRNA synthetase) Ab
    PL-7 (threonyl-tRNA synthetase) Ab
    PM/Scl 100 Ab, IgG
    Rheumatoid Factor
    Scleroderma (Scl-70) (ENA) Ab, IgG
    SRP (Signal Recognition Particle) Ab
    SSA 52 (Ro) (ENA) Ab, IgG
    SSA 60 (Ro) (ENA) Ab, IgG
  • Ordering Guidance:
    May be useful for evaluation of interstitial lung disease in the context of connective tissue disease.
  • Spec Type:
    Serum
  • Spec Container:
    Gold top (SST) or Red top (serum) tube
  • Pref Vol:
    5 mL
  • Min Vol:
    2.5 mL
  • Spec Collect:
    Normal phlebotomy procedure. Mix by inverting tube 5 times.
  • Spec Process:
    Separate serum from cells ASAP or within 2 hours of collection. Transfer five serum aliquots to screw-capped plastic transport tubes. (Min: 0.5 mL per aliquot)
  • Spec Store Transport:
    Refrigerated.
  • Spec Stability:
    Room temperature: 24 hours
    Refrigerated: 1 week
    Frozen: 1 month
  • Spec Reject:
    Hemolyzed, hyperlipemic, icteric, heat-treated or contaminated specimens.
  • Methodology:
    Qualitative Immunoprecipitation; Semi-Quantitative Multiplex Bead Assay; Qualitative Immunoblot; Semi-Quantitative Enzyme-Linked Immunosorbent Assay (ELISA); Quantitative Immunoturbidimetry
  • Interpretive Data:

    See Laboratory Report

    Compliance Statement D: For laboratory tests using a manufactured RUO kit. This test was developed and its performance characteristics determined by ARUP Laboratories. The U. S. Food and Drug Administration has not approved or cleared this test; however, FDA clearance or approval is not currently required for clinical use. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions.

  • Note:
    Antibodies: Ro52, Ro60, Jo-1, PL-7, PL12, EJ, Ku, SRP, OJ, PM/Scl-100, MDA5, CCP, Scl-70, RA, ANA, NXP-2
  • Additional Test Info:
    Additional Technical Information
  • Day Run:
    Mon, Tue, Thu, Fri
  • Time Reported:
    8-16 days
  • Test Type:
    IMMUNOLOGY